CM Management’s BioCardia BCDA Stock Holding History

CM Management’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$372K	Buy	300,000 +170,000	+131%	+$179K	0.24%	70
2026 Q1	$157K	Hold	130,000	–	–	0.13%	70
2025 Q4	$163K	Hold	130,000	–	–	0.14%	62
2025 Q3	$168K	Hold	130,000	–	–	0.14%	64
2025 Q2	$254K	Buy	130,000 +55,000	+73%	+$122K	0.23%	64
2025 Q1	$191K	Buy	75,000 +50,000	+200%	+$121K	0.19%	52
2024 Q4	$54.5K	Buy	+25,000	New	+$58.6K	0.05%	57
2024 Q2	–	Sell	-46,667	Closed	-$285K	–	65
2024 Q1	$285K	Hold	46,667	–	–	0.24%	65
2023 Q4	$465K	Buy	46,667 +6,667	+17%	+$54.1K	0.37%	58
2023 Q3	$258K	Buy	40,000 +17,133	+75%	+$288K	0.27%	59
2023 Q2	$916K	Buy	22,867 +934	+4%	+$28.8K	0.89%	36
2023 Q1	$642K	Hold	21,933	–	–	0.76%	41
2022 Q4	$688K	Hold	21,933	–	–	0.82%	39
2022 Q3	$638K	Hold	21,933	–	–	0.71%	48
2022 Q2	$477K	Hold	21,933	–	–	0.51%	56
2022 Q1	$681K	Hold	21,933	–	–	0.57%	54
2021 Q4	$638K	Hold	21,933	–	–	0.48%	63
2021 Q3	$1.03M	Hold	21,933	–	–	0.77%	45
2021 Q2	$1.31M	Buy	21,933 +1,060	+5%	+$64.4K	0.94%	40
2021 Q1	$1.36M	Buy	20,873 +5,540	+36%	+$346K	1.01%	35
2020 Q4	$796K	Buy	+15,333	New	+$612K	0.74%	47

Other funds holding BCDA

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

CM Management's BCDA Position: Q2 2026 in Review

CM Management increased its BioCardia (BCDA) stake by 131% in Q2 2026, buying an estimated $179K and bringing the position to 300,000 shares worth $372K. The position accounts for 0.24% of the portfolio, ranked #70.

CM Management first reported a position in BCDA in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.36M in Q1 2021. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

CM Management held 300,000 shares of BioCardia worth $372K as of Q2 2026.
CM Management bought 170,000 BioCardia shares in Q2 2026, an estimated $179K.
BioCardia made up 0.24% of CM Management's portfolio in Q2 2026, its #70 holding.
CM Management first reported a position in BioCardia in Q4 2020 and has held it in 21 quarters since.
CM Management's BioCardia position peaked at $1.36M in Q1 2021.
21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.